Meaningful Use Help

Happy 2017 to all our readers out there, with the upcoming changes in healthcare reform, getting help with demonstrating meaningful use could be more important than ever before. Right now we are in modified stage 2 until the end of 2017. By the time we reach 2018 all healthcare providers will be required to move to Stage 3 Meaningful Use. This program will also become one component of the Merit Based Incentive Program based on this years reporting. Here is what we can do to offer meaningful use help this 2017.

Meaningful Use Help Defined

There are 10 mandatory objectives for Meaningful Use Stage 2 and this is what iHealthOne can help with.

  • Protect Patient Health Information
  • Clinical Decision Support
  • Computerized Provider Order Entry (CPOE)
  • Electronic Prescribing
  • Health Information Exchange
  • Patient-Specific Information
  • Medication Reconciliation
  • Patient Electronic Access
  • Secure Messaging
  • Public Health

Protecting Patient Health Information

This measure requires your practice to conduct a security risk analysis and implement necessary security updates as necessary. Furthermore, you must correct identified security deficiencies as part of the eligible professionals risk management process.

Clinical Decision Support

Measure 1: This measure requires your practice to implement five clinical decision support interventions related to four or more clinical quality measures at a relevant point in patient care for the entire electronic health record reporting period. Absent four clinical quality measures related to an eligible professionals scope of patient population or practice, the clinical decision support interventions must be related to high-priority health conditions.

Measure 2: The eligible professional has enabled and implemented the functionality for drug and drug-allergy interaction checks for the entire EHR reporting period.


Computerized Provider Order Entry (CPOE)


Measure 1: More than 60 percent of medication orders created by the EP during the EHR reporting period are recorded using CPOE.

Measure 2: More than 30 percent of the laboratory orders created by the EP during the EHR reporting period are recoded using CPOE.

Measure 3: More than 30 percent of radiology orders created by the EP during the EHR reporting period are recorded using CPOE.


Electronic Prescribing

Measure: More than 50 percent of all permissible prescriptions written by the EP are queried for a drug formulary and transmitted electronically using CEHRT.


Health Information Exchange

Measure: The EP that transitions or refers their patient to another setting of care or provider of care (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving provider for more than 10% of transitions of care and referrals.

Patient-Specific Information

Measure: Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all unique patients with office visits seen by the EP during the EHR reporting period.

Medication Reconciliation

Measure: The EP performs medication reconciliation for mroe than 50% of transitions of care in which the patient is transitioned into the care of the EP.

Patient Electronic Access

Measure 1: More than 50% of all unique patients seen by the EP during the EHR reporting period are provided timely access to view online, download, and transmit to a third party their health information subject to the EP’s discretion to withhold certain information.

Secure Messaging

Measure: For 2017: For more than 5% of unique patients seen by the EP during the EHR reporting period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure message sent by the patient (or the patient-authorized representative) during the EHR reporting period.

Public Health

Measure 1: Immunization Registry Reporting: The EP is in active engagement with a public health agency to submit immunization data.
Measure 2: Syndromic Surveillance Reporting: The EP is in active engagement with a public health agency to submit syndromic surveillance data.
Measure 3: Specialized Registry Reporting – The EP is in active aengagement to submit data to a specialized registry.

Meaningful Use Help From iHealthOne.

Give us a call or email today for your first free consultations. We are in the practice of helping practices everywhere demonstrate meaningful use and avoid costly penalties. You have a busy practice to run and we have done all of the research already in this area. We can get done what would take many hours to learn how to do for yourself in less than half the time at a much lower cost than paying costly in house staff.

We’ve worked already with thousands of practices across the United States, when you work with us you will see the difference we bring to the healthcare compliance consulting industry. We aim to be number one in the area of meaningful use help. If you have any questions or comments please email and we’ll get right back to you.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *